revolution plus (selamectin/sarolaner) monthly topical solution for small cats and kittens 1.25 – 2.5 kg
zoetis australia pty ltd - selamectin; sarolaner - topical solution/suspension - selamectin anthelmintic active 60.0 mg/ml; sarolaner active 10.0 mg/ml - parasiticides
revolution plus (selamectin/sarolaner) monthly topical solution for medium cats 2.6 – 5 kg
zoetis australia pty ltd - selamectin; sarolaner - topical solution/suspension - selamectin anthelmintic active 60.0 mg/ml; sarolaner active 10.0 mg/ml - parasiticides
revolution plus (selamectin/sarolaner) monthly topical solution for large cats 5.1 – 10 kg
zoetis australia pty ltd - selamectin; sarolaner - topical solution/suspension - selamectin anthelmintic active 60.0 mg/ml; sarolaner active 10.0 mg/ml - parasiticides
simparica
zoetis new zealand limited - sarolaner - sarolaner 40 g/kg - ectoparasiticide
sarolaner
zoetis australia pty ltd - sarolaner - unknown - sarolaner active 0.0 - active constituent
simparica
zoetis belgium sa - sarolaner - ectoparasiticides for systemic use - dogs - for the treatment of tick infestations (dermacentor reticulatus, ixodes hexagonus, ixodes ricinus and rhipicephalus sanguineus). the veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks.for the treatment of flea infestations (ctenocephalides felis and ctenocephalides canis). the veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks. the veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of sarcoptic mange (sarcoptes scabiei).for the treatment of ear mite infestations (otodectes cynotis).for the treatment of demodicosis (demodex canis).fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
mipet easecto
zoetis belgium sa - sarolaner - ectoparasiticides for systemic use - dogs - for the treatment of tick infestations (dermacentor reticulatus, ixodes hexagonus,ixodes ricinus and rhipicephalus sanguineus). the veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks. for the treatment of flea infestations (ctenocephalides felis and ctenocephalides canis). the veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks. the veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad). for the treatment of sarcoptic mange (sarcoptes scabiei). for the treatment of ear mite infestations (otodectes cynotis). for the treatment of demodicosis (demodex canis). fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.,
simparica trio
zoetis belgium s.a. - moxidectin, sarolaner, pyrantel embonate - antiparasitics - dogs - for dogs with, or at risk from, mixed external and internal parasitic infestations. the veterinary medicinal product is exclusively indicated when use against ticks or fleas and gastrointestinal nematodes is indicated at the same time. the veterinary medicinal product also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis.ectoparasitesfor the treatment of tick infestations. the veterinary medicinal product has immediate and persistent tick killing activity for 5 weeks against ixodes hexagonus, ixodes ricinus and rhipicephalus sanguineus and for 4 weeks against dermacentor reticulatus;for the treatment of flea infestations (ctenocephalides felis and ctenocephalides canis). the veterinary medicinal product has immediate and persistent flea killing activity against new infestations for 5 weeks;the veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).gastrointestinal nematodesfor the treatment of gastrointestinal roundworm and hookworm infections:toxocara canis immature adults (l5) and adults;ancylostoma caninum l4 larvae, immature adults (l5) and adults;toxascaris leonina adults;uncinaria stenocephala adults.other nematodesfor the prevention of heartworm disease (dirofilaria immitis);for the prevention of angiostrongylosis by reducing the level of infection with immature adult (l5) stages of angiostrongylus vasorum.
simparica trio- sarolaner, moxidectin, and pyrantel tablet, chewable
zoetis inc. - sarolaner (unii: dm113ftw7f) (sarolaner - unii:dm113ftw7f), moxidectin (unii: ngu5h31yo9) (moxidectin - unii:ngu5h31yo9), pyrantel pamoate (unii: 81bk194z5m) (pyrantel - unii:4qih0n49e7) - simparica trio is indicated for the prevention of heartworm disease caused by dirofilaria immitis and for the treatment and control of roundworm (immature adult and adult toxocara canis and adult toxascaris leonina ) and hookworm (l4, immature adult, and adult ancylostoma caninum and adult uncinaria stenocephala ) infections. simparica trio kills adult fleas (ctenocephalides felis ) and is indicated for the treatment and prevention of flea infestations, and the treatment and control of tick infestations with amblyomma americanum (lone star tick), amblyomma maculatum (gulf coast tick), dermacentor variabilis (american dog tick), ixodes scapularis (blacklegged tick), and rhipicephalus sanguineus (brown dog tick) for one month in dogs and puppies 8 weeks of age and older, and weighing 2.8 pounds or greater. simparica trio is indicated for the prevention of borrelia burgdorferi infections as a direct result of killing ixodes scapularis vector ticks. there are no known contraindications for the use of simparica trio.
simparica 10mg chewable tablet
zoetis philippines, inc. - sarolaner (vet.) - chewable tablet - 10mg